[1]焦建同,黄进,程超,等.Survivin在脑膜瘤的表达特点及其预测预后的价值[J].临床神经外科杂志,2018,15(04):241-245.
 JIAO Jian-tong,HUANG Jin,CHENG Chao,et al.Expression characteristic and prognostic value of survivin in meningioma[J].Journal of Clinical Neurosurgery,2018,15(04):241-245.
点击复制

Survivin在脑膜瘤的表达特点及其预测预后的价值()
分享到:

《临床神经外科杂志》[ISSN:1672-7770/CN:32-1727/R]

卷:
15
期数:
2018年04期
页码:
241-245
栏目:
实验研究专题
出版日期:
2018-08-15

文章信息/Info

Title:
Expression characteristic and prognostic value of survivin in meningioma
作者:
焦建同黄进程超黄维一王龙赵一清邵君飞
214023无锡,南京医科大学附属无锡市人民医院神经外科(焦建同,黄进,程超,黄维一,邵君飞);长治医学院附属和平医院神经外科(王龙);华中科技大学附属同济医院神经外科(赵一清)
Author(s):
JIAO Jian-tongHUANG JinCHENG Chaoet al.
Department of Neurosurgery,Wuxi People's Hospital Affiliated to Nanjing Medical University,Wuxi 214023,China
关键词:
survivin脑膜瘤无复发生存期生存期浓度评分
Keywords:
survivinmeningiomasrecurrence-free survivalintensity distribution score
分类号:
R739.45
文献标志码:
A
摘要:
目的 探讨survivin在脑膜瘤的表达特点及其与预后的关系。方法 采用免疫组化法检测121例脑膜瘤患者手术切除的脑膜瘤标本的survivin表达水平;并收集患者的临床资料,分析survivin浓度分布评分(IDS)与临床指标的关系。结果 WHOⅠ、Ⅱ、Ⅲ级脑膜瘤患者的survivin IDS分别是3.05±3.21、7.86±2.19和10.00±1.87,Ⅱ、Ⅲ级脑膜瘤患者的survivin IDS明显高于Ⅰ级脑膜瘤(均P<0.001)。无复发和复发、未死亡和死亡患者的survivin IDS分别是2.84±2.84和6.27±3.94、3.23±2.92和6.68±4.53;与无复发或未死亡患者相比,复发和死亡患者的survivin IDS明显增高(均P<0.001)。与survivin IDS 0~4组相比,IDS 6~12组患者的复发和死亡风险分别增高12倍和3倍,且无复发生存期和生存期均明显缩短(P<0.005-0.001)。结论 Survivin在脑膜瘤的发生、发展中发挥了重要作用,可作为预测脑膜瘤不良预后的有效指标。
Abstract:
Objective To investigate the expression characteristic and prognostic value of survivin in meningioma.Methods The expression characteristic of survivin was analyzed in 121 meningiomas by immunohistochemistry.Then,the clinical parameters of patients were collected and the relationship between survivin intensity distribution score (IDS) and the clinical parameters were analyzed.Results Survivin IDS in Ⅰ、Ⅱ、Ⅲ grade meningiomas were 3.05±3.21,7.86±2.19 and 10.00±1.87 respectively.Compared to survivin IDS in Ⅰ grade meningioma,survivin IDS in Ⅱ,Ⅲ grade cases significantly increased(all P<0.001).In recurrent free,recurrent,alive and dead cases,survivin IDS were 2.84±2.84,6.27±3.94,3.23±2.92 and 6.68±4.53 respectively.Compared with survivin IDS in recurrence free or alive cases,survivin IDS in recurrent or dead cases was significantly increased(all P<0.001).The risk of recurrence or mortality in survivin IDS 6-12 group was higher than those in IDS 0-4 group,and the risk was up to 12 or 3 folds respectively.In addition,the recurrence-free survival in IDS 6-12 group was significantly shorter than those in IDS 0-4 group(P<0.005-0.001).Conclusion Survivin plays an important role in the development of meningiomas.It can be used as one of indicators in the prognosis of meningioma.

相似文献/References:

[1]陈立华.岩斜区脑膜瘤手术入路选择[J].临床神经外科杂志,2014,(01):1.
[2]马涛,秦华平,官卫.术前辅助栓塞联合手术治疗脑膜瘤的Meta分析[J].临床神经外科杂志,2014,(01):41.
[3]唐知己,杨瑞金,张珍华,等.皮质中央区脑膜瘤术后神经功能障碍的预防[J].临床神经外科杂志,2015,(02):129.
[4]殷尚炯,刘洪泉,王洪生.侵袭性脑膜瘤的诊断和治疗[J].临床神经外科杂志,2015,(04):287.
[5]苏卢海,张世渊,沈波,等.脑膜瘤3次术后并发腹腔间隔室综合征1例诊治临床分析并文献复习[J].临床神经外科杂志,2015,(06):479.
[6]李正阳,吾太华,郑传红,等.uPAR通过调节MMP2和MMP9对恶性脑膜瘤的侵袭有促进作用[J].临床神经外科杂志,2014,(05):335.
[7]蒋霖,高广忠.大型矢状窦旁脑膜瘤显微外科治疗[J].临床神经外科杂志,2014,(05):389.
[8]吴长山,范月超.小脑幕脑膜瘤的显微外科手术治疗[J].临床神经外科杂志,2016,(04):249.
 WU Chang-shan,FAN Yue-chao.Microsurgical treatment of tentorial meninsiomas[J].Journal of Clinical Neurosurgery,2016,(04):249.
[9]李国峰,侯文仲,曾敏敏,等.大脑镰及矢状窦旁脑膜瘤显微手术治疗的研究[J].临床神经外科杂志,2016,(04):252.
 LI Guo-feng,HOU Wen-zhong,ZENG Min-min,et al.Study of surgical treatment of the cerebral falx and parasagittal meningiomas[J].Journal of Clinical Neurosurgery,2016,(04):252.
[10]卢成寅,徐涛,王洪祥,等.幕上脑膜瘤手术并发症的相关因素[J].临床神经外科杂志,2017,14(03):202.
 LU Cheng-yin,XU Tao,WANG Hong-xiang,et al.Related factors of surgical complications in patients with supratentorial meningiomas[J].Journal of Clinical Neurosurgery,2017,14(04):202.

更新日期/Last Update: 1900-01-01